Spotlight

UCL cancer immunotherapy company, Autolus, launches with £30m investment

A new UCL spin-out company – Autolus – is being launched today to develop and commercialise a new generation of engineered T-cell therapies for haematological and solid tumours, with the backing of £30m in investment from healthcare investment company Syncona.

Find out more



follow us on twitter


A Culture of Success Will be the Olympics' Greatest Legacy

14 August 2012

By Stephen Caddick, Vice-Provost (Enterprise) at UCL
Britain's haul of gold medals in the Olympics has changed the nation's perceptions of our small island: we can emphatically be winners.

Now is the time to celebrate Britain's success across more than just sport - our country, and London in particular, has quietly become one of the most amazing new hubs for digital, media and start-ups in the whole of Europe.

Read the full article at www.huffingtonpost.co.uk